Agranulocytosis associated with tricyclics

Area of Science:

• Pharmacology
• Hematology
• Clinical Toxicology

Background:

• Tricyclic antidepressants (TCAs) are widely prescribed for various psychiatric conditions.
• Adverse drug reactions associated with TCAs can range from mild to life-threatening.
• Agranulocytosis, a severe reduction in white blood cells, is a known but infrequent complication of certain medications.

Observation:

• This report details a specific case of agranulocytosis.
• The agranulocytosis was strongly associated with the use of Imipramine, a commonly prescribed TCA.
• The patient presented with characteristic clinical and laboratory findings indicative of this severe hematologic condition.

Findings:

• Imipramine-induced agranulocytosis is a rare but hazardous adverse drug event.
• Literature review confirms this association as a significant risk with tricyclic antidepressant therapy.
• The case provides valuable data on the syndrome's presentation and potential pathogenetic mechanisms.

Implications:

• Early recognition and prompt management are crucial for improving outcomes in Imipramine-associated agranulocytosis.
• This case underscores the importance of monitoring blood counts in patients on TCAs, particularly those with suggestive symptoms.
• Further research into the pathogenesis may lead to predictive markers or preventative strategies for this dangerous side effect.